QUEST DIAGNOSTICS INC (DGX)

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q1 2024

DGX stock results show that Quest Diagnostics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

S&P 500 Movers: MSCI, DGX

What's going on in today's pre-market session: S&P500 movers

The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.

Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the...

Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new blood biomarker test for...

Liberty Media Larger Than S&P 500 Component Quest Diagnostics

Balancing Dividends and Fundamentals: The Case of NYSE:DGX.

Uncovering Dividend Opportunities with QUEST DIAGNOSTICS INC (NYSE:DGX).

Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and Broad Clinical Labs, the world expert in whole genome...

Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease

/PRNewswire/ -- A blood test that analyzes levels of amyloid proteins by highly sensitive mass spectrometry could help physicians establish that Alzheimer's...

Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2024...

Interesting DGX Put And Call Options For November 15th

Interesting DGX Put And Call Options For December 20th

Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and...

Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery Delivery

/PRNewswire/ -- Pack Health, a Quest Diagnostics (NYSE: DGX) company specializing in patient engagement, and Instacart (NASDAQ: CART), the leading grocery...

Interesting DGX Put And Call Options For April 19th

Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection

/PRNewswire/ -- Freenome, a biotechnology company developing blood tests for early cancer detection, announced the addition of $254 million from new and...

Quest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive Surgery

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced the launch of MelaNodal...

First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leader in diagnostic information services, today announced the availability of the first...

Jefferies upgrades Quest to buy, sees 2024 guidance as conservative (NYSE:DGX)

Jefferies has upgraded Quest Diagnostics (DGX) to buy due to "compelling" valuation and "conservative" fiscal 2024 guidance. The investment bank said it believe

Quest Diagnostics raises dividend by 6% to $0.75 (NYSE:DGX)

Quest Diagnostics (DGX) declares $0.75/share quarterly dividend, 5.6% increase from prior dividend of $0.71. Forward yield 2.34% Payable April 22; for sharehold

Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share

Fourth quarter revenues of $2.29 billion, down 1.9% from 2022 Fourth quarter reported diluted earnings per share ("EPS") of $1.70, up 95.4% from 2022; and...